Sarcoma de Kaposi en personas que viven con VIH-Sida en un hospital público de referencia en Perú

Bibliographic Data

ID15534487
AuthorsLucía Maryelena Mendoza Mori (0000-0002-3393-2619, Universidad Peruana Cayetano Heredia, corresponding author), Jim Brian Valenzuela Medina (0000-0002-8121-9367, Instituto de Medicina Tropical), Eduardo Gotuzzo (0000-0003-1747-4352, Universidad Peruana Cayetano Heredia), Francisco Bravo (0000-0001-7348-6695), Francisco Gerardo Bravo Puccio (0000-0001-6584-0391, Universidad Peruana Cayetano Heredia), Fernando Mejia (0000-0001-8429-8833, Instituto de Medicina Tropical), Salim Mohanna (0000-0002-1486-3259, Universidad Peruana Cayetano Heredia), Elsa González-Lagos (0000-0002-8543-8188, Instituto de Medicina Tropical)
Year2022
Volume39
Issue3
Pages352-6
Publication date2022-09-30
Open AccessYes
TypeARTICLE
VenueRevista Peruana de Medicina Experimental y Salud Pública (JOURNAL)
Journal identifiersISSN: 1726-4634 • E-ISSN: 1726-4642
PublisherNational Institute of Health of Peru (PUBLISHER • PE)
DOI10.17843/rpmesp.2022.393.10883
PMID36478169
OpenAlexW4308291754
LanguageES

Kaposi's sarcoma (KS) is the most frequent cancer in people living with HIV. Research on this condition is scarce in the region, therefore, this article aimed to describe the demographic, clinical and therapeutic characteristics of patients with HIV who developed KS at the Cayetano Heredia Hospital between 2000 and 2018. A total of 129 KS cases were identified, with a median age of 33 years, predominantly males with 92% (119/129), and mostly men who have sex with men (MSM). The median time from HIV diagnosis to KS diagnosis was five months, associated with a CD4 lymphocyte count of 64 cells/μL (IQR: 33-185) at KS diagnosis. Cutaneous involvement was the most common presentation; however, at least half also had the visceral form

Art · Gynecology · Human immunodeficiency virus (HIV · Humanities · Pathology · Sarcoma · Lymphoma Diagnosis and Treatment · Medicine · Viral-associated cancers and disorders · Virology